Rotavirus is the major etiologic factor of severe diarrheal disease. Natural infection provides protection against subsequent rotavirus infection and diarrhea. This research presents a new vaccine designed based on computational models. In this study, three types of epitopes are considered—linear, conformational, and combinational—in a proposed model protein. Several studies on rotavirus vaccines have shown that VP6 and VP4 proteins are good candidates for vaccine production. In the present study, a fusion protein was designed as a new generation of rotavirus vaccines by bioinformatics analyses. This model-based study using ABCpred, BCPREDS, Bcepred, and Ellipro web servers showed that the peptide presented in this article has the necessary properties to act as a vaccine. Prediction of linear B-cell epitopes of peptides is helpful to investigate whether these peptides are able to activate humoral immunity.
Get full access to this article
View all access options for this article.
References
1.
AdamsHP, and KoziolJ. Prediction of binding to MHC class I molecules. Immunol Methods, 1995; 185:181–190.
2.
AiyegboMS, SapparapuG, SpillerB, et al.Human rotavirus VP6-specific antibodies mediate intracellular neutralization by binding to a quaternary structure in the transcriptional pore. PLoS One, 2013; 8:e61101.
3.
BhasinM, and RaghavaG. SVM based method for predicting HLA-DRB1*0401 binding peptides in an antigen sequence. Bioinformatics, 2004; 20:421–423.
4.
BhasinM, and RaghavaG. Analysis and prediction of affinity of TAP binding peptides using cascade SVM. Protein Sci, 2004; 13:596–607.
5.
BhasinM, and RaghavaG. Prediction of CTL epitopes using QM, SVM and ANN techniques. Vaccine, 2004; 22:3195–3204.
6.
BlackRE, CousensS, JohnsonHL, et al.Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet, 2010; 375:1969–1987.
7.
BridgerJC, and OldhamG. Novel rotaviruses in animals and man. Clin Microbiol, 1987; 128:6–23.
8.
ChenP, RaynerS, and HuK. Advances of bioinformatics tools applied in virus epitopes prediction. Virol Sin, 2011; 26:1–7.
9.
ClarkHF, HoshinoY, BellLM, et al.Rotavirus isolate WI61 representing a presumptive new human serotype. Clin Microbiol, 1987; 25:1757–1762.
10.
ColeC, BarberJ, and BartonG. The Jpred 3 secondary structure prediction server. Nucleic Acids Res, 2008; 36:W197–201.
11.
DennehyPH, VesikariT, MatsonDO, et al.Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen). Human Vaccines, 2011; 7:563–568.
12.
DonatoCM, CannanaD, Bogdanovic-SakranaN, et al.Characterisation of a G9P[8] rotavirus strain identified during a gastroenteritis outbreak in Alice Springs, Australia post Rotarix™ vaccine introduction. Vaccine, 2012; 30:152–158.
13.
DonatoCM, Ch'ngLS, BonifaceKF, et al.Identification of strains of RotaTeq rotavirus vaccine in infants with gastroenteritis following routine vaccination. J Infect Dis, 2012; 375:377–383.
14.
DoytchinovaIA, GuanP, and FlowerD. EpiJen: a server for multistep T cell epitope prediction. BMC Bioinformatics, 2006; 7:131.
15.
El-ManzalawyY, DobbsD, and HonavarV. Predicting linear B-cell epitopes using string kernels. J Mol Recognit, 2008; 21:243–255.
16.
EstesKM, and CohenJ. Rotavirus gene structure and function. Microbiol Rev, 1989; 53:410–449.
17.
EstesMK, KnipeDM, HowleyPM, et al.Rotaviruses and their replication. Virology, 2007; 1917–1974.
18.
Fernandez-FuentesN, Madrid-AlisteC, RaiB, et al.M4T: a comparative protein structure modeling server. Nucleic Acids Res, 2007; 35:W363–368.
19.
GaraicoecheaL, OlichonA, MarcoppidoG, et al.Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice. Virology, 2008; 28:9753–9764.
20.
GarrisonKE, ChampiatS, YorkV, et al.Transcriptional errors in human immunodeficiency virus type 1 generate targets for T-cell responses. Clin Vaccine Immunol, 2009; 16:1369–1371.
21.
GentschJR, WoodsPA, RamachandranM, et al.Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development. Infect Dis, 1996; 174:S30–S36.
22.
GrimwoodK, and LambertSB. Rotavirus vaccines: opportunities and challenges. Hum Vaccines, 2009; 5:57–69.
23.
KapikianAZ, HoshinoY, and ChanokRM. Rotaviruses. Fields Virol, 2001; 2:1787–1833.
24.
KelleyLA, and SternbergM. Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc, 2009; 4:363–371.
25.
KnutsonKL, and DisisM. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol Immunother, 2005; 54:721–728.
26.
KringelumJV, LundegaardC, LundO, et al.Reliable B cell epitope predictions: impacts of method development and improved benchmarking. PLoS Comput Biol, 2012; 8:e1002829.
27.
LarsenMV, LundegaardC, LamberthK, et al.Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics, 2007; 8:424.
28.
LataS, BhasinM, and RaghavaG. Application of machine learning techniques in predicting MHC binders. Methods Mol Biol, 2007; 409:201–215.
29.
LiZ, ZhangM, HuH, et al.[On predicting the T cell and B cell epitopes of platelet membrane glycoprotein II b/III a antibody from human and mice]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 2011; 27:1146–1151.
30.
LiangS, ZhengD, ZhangC, et al.Prediction of antigenic epitopes on protein surfaces by consensus scoring. BMC Bioinformatics, 2009; 10:302.
31.
McGuffinLJ, BrysonK, and JonesD. The PSIPRED protein structure prediction server. Bioinformatics, 2000; 16:404–405.
32.
NakagomiT, OhshimaA, AkataniK, et al.Isolation and molecular characterization of a serotype 9 human rotavirus strain. Microbiol Immunol, 1990; 34:77–82.
33.
OffitPA, HoffenbergE, SantosN, et al.Rotavirus-specific humoral and cellular immune response after primary, symptomatic infection. J Infect Dis, 1993; 167:1436–1440.
34.
ParasharUD, BurtonA, LanataC, et al.Global mortality associated with rotavirus disease among children in 2004. Infect Dis, 2009; 200:9–15.
35.
ParasharUD, GibsonCJ, BreseeJS, et al.Rotavirus and severe childhood diarrhea. Emerg Infect Dis, 2006; 12:304–306.
36.
ParasharUM, HummelmanEG, BreseeGS, et al.Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis, 2003; 9:565–572.
37.
PatelM, SteeleD, GentschJR, et al.Real-world impact of rotavirus vaccination. Infect Dis J, 2011; 30:S1–5.
38.
PenelopeH. Rotavirus vaccines: an overview. Clin Microbiol Rev, 2008; 21:198–208.
39.
PhuaKB, EmmanuelSC, GohP, et al.A rotavirus vaccine for infants: the Asian experience. Ann Acad Med Singapore, 2006; 35:38–44.
40.
PonomarenkoJ, BuiH, LiW, et al.ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics, 2008; 9:514.
41.
RaiJ, LokK, MokC, et al.Immunoinformatic evaluation of multiple epitope ensembles as vaccine candidates: E. coli 536. Bioinformation, 2012; 8:272–275.
42.
ReimerU. Prediction of linear B-cell epitopes. Methods Mol Biol, 2009; 524:335–344.
43.
RennelsMB, GlassRI, DennehyPH, et al.Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccine. Pediatrics, 1996; 97:7–13.
44.
RossiG, CornaroC, BattilaniM, et al.Production of IFN-gamma in feline whole blood after incubation with potential T-cell epitopes of the nucleocapsid protein of feline coronavirus. Vet Microbiol, 2011; 150; 248 (248–256).
45.
RostB, and SanderC. Prediction of protein secondary structure at better than 70% accuracy. J Mol Biol, 1993; 232:458–459.
46.
SahaS, and RaghavaG. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins, 2006; 65:40–48.
47.
SahaS, and RaghavaG. Prediction methods for B-cell epitopes. Methods Mol Biol, 2007; 409:387–394.
48.
SahaS, RaghavaGPS. 2004. BcePred: Prediction of continuous B-cell epitopes in antigenic sequences using physico-chemical properties. In ICARIS 2004, LNCS, vol. 3239. NicosiaG., CutelloV., BentleyP.J. and TimisJ. (eds). Springer, UK, 197–204.
49.
SinghH, and RaghavaG. ProPred1: prediction of promiscuous MHC Class-I binding sites. Bioinformatics, 2003; 19:1009–1014.
50.
Vasil'evB, MoskvinA, MarchenkoL, et al.[Indicators of humoral immunity in rotavirus infection among various age groups of St. Petersburg residents from CFT data]. Vopr Virusol, 1995; 40:129–130.
51.
WardRL, and BernsteinDI. Rotarix: a rotavirus vaccine for the world. Vaccine, 2009; 48:222–228.
52.
WiddowsonMA, SteeleD, VojdaniJ, et al.Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines. Infect Dis, 2009; 200:S1–8.
53.
WilliamsMB, RoseJ, RottL, et al.The memory B cell subset responsible for the secretory IgA response and protective humoral immunity to rotavirus expresses the intestinal homing receptor, alpha4beta7. Immunol, 1998; 161:4227–4235.
54.
ZhangW, XiongY, ZhaoM, et al.Prediction of conformational B-cell epitopes from 3D structures by random forests with a distance-based feature. BMC Bioinformatics, 2011; 12:341.
55.
ZhangW, LiuJ, and ZhaoM. Predicting linear B-cell epitopes by using sequence-derived structural and physicochemical features. Int J Data Min Bioinform, 2012; 6:557–569.
